Solara Active Pharma Sciences Limited has informed the Exchange about the Schedule of Investors/Analysts call to be held on Friday, May 15, 2026 at 15.00 IST, to discuss the Company''s ....
SOLARA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Solara Active Pharma Sciences has scheduled an analysts/investors conference call for Friday, May 15, 2026 at 3:00 PM IST. The call will discuss the company's audited financial results for Q4 and the financial year ended March 31, 2026. Senior management including Founder & Non-Executive Director Arun Kumar, MD & CEO Sandeep Rao, and CFO Sarat Kumar will participate. The meeting is being disclosed to BSE and NSE in compliance with securities regulations. Dial-in access numbers and a Diamond Pass early registration option are provided.
This is a standard post-results investor engagement event. The participation of the CEO and CFO signals availability for analyst Q&A. The disclosed schedule provides advance notice allowing investors and analysts to plan attendance.